Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LAZERTINIB: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

59.9%
Female
40.1%
Male

Age Information

The average age of patients reporting adverse events with LAZERTINIB is 66.6 years.

Geographic Distribution

The majority of adverse event reports for LAZERTINIB originate from US.

Report Summary & Outcomes

352
Total Reports
352
As Primary/Secondary Suspect
15
Deaths Reported
83
Hospitalizations
6
Life-Threatening
2
Disabilities

Reporting Timeline

First adverse event report: 20210101. Most recent report: 20250908. View full timeline →

More About LAZERTINIB

LAZERTINIB Full Profile Reports by Year Drug Interactions